Literature DB >> 27004001

Negative short-term impact of intraoperative biliary lavage in patients with hepatolithiasis.

Ou Jiang1, Rong-Xing Zhou1, Ke Yang1, Chun-Xian Cai1, Yu Liu1, Nan-Sheng Cheng1.   

Abstract

AIM: To evaluate short-term outcomes following intraoperative biliary lavage for hepatolithiasis.
METHODS: A total of 932 patients who were admitted to the West China Medical Center of Sichuan University between January 2010 and January 2014 and underwent bile duct exploration and lithotomy were retrospectively included in our study. The patients were divided into the lavage group and the control group. Related pre-, intra-, and postoperative factors were recorded, analyzed, and compared between the two groups in order to verify the effects of biliary lavage on the short-term outcome of patients with hepatolithiasis.
RESULTS: Amongst the patients who were included, 678 patients with hepatolithiasis were included in the lavage group, and the other 254 patients were enrolled in the control group. Data analyses revealed that preoperative baseline and related intraoperative variables were not significantly different. However, patients who underwent intraoperative biliary lavage had prolonged postoperative hospital stays (6.67 d vs 7.82 d, P = 0.024), higher hospitalization fees (RMB 28437.1 vs RMB 32264.2, P = 0.043), higher positive rates of bacterial cultures from blood (13.3% vs 25.8%, P = 0.001) and bile (23.6% vs 40.7%, P = 0.001) samples, and increased usage of advanced antibiotics (26.3% vs 38.2%, P = 0.001). In addition, in the lavage group, more patients had fever (> 37.5 °C, 81.4% vs 91.1%, P = 0.001) and hyperthermia (> 38.5°C, 39.7% vs 54.9%, P = 0.001), and higher white blood cell counts within 7 d after the operation compared to the control group.
CONCLUSION: Intraoperative biliary lavage might increase the risk of postoperative infection, while not significantly increasing gallstone removal rate.

Entities:  

Keywords:  Biliary lavage; Hepatolithiasis; Postoperative infection

Mesh:

Substances:

Year:  2016        PMID: 27004001      PMCID: PMC4789999          DOI: 10.3748/wjg.v22.i11.3234

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Epidemiology and prognostic determinants of bacteraemic biliary tract infection.

Authors:  M Ortega; F Marco; A Soriano; M Almela; J A Martínez; J López; C Pitart; J Mensa
Journal:  J Antimicrob Chemother       Date:  2012-03-09       Impact factor: 5.790

2.  Optimizing biliary stent patency by coating with hydrophobin alone or hydrophobin and antibiotics or heparin: an in vitro proof of principle study.

Authors:  U Weickert; F Wiesend; T Subkowski; A Eickhoff; G Reiss
Journal:  Adv Med Sci       Date:  2011       Impact factor: 3.287

3.  Isolated bacteria and susceptibilities to antimicrobial agents in biliary infections.

Authors:  Mitsuhiro Mukaiya; Koichi Hirata; Tadashi Katsuramaki; Chikashi Kihara; Yasutoshi Kimura; Koji Yamaguchi; Tomohisa Furuhata; Fumitake Hata
Journal:  Hepatogastroenterology       Date:  2005 May-Jun

4.  Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis.

Authors:  Young Koog Cheon; Young Deok Cho; Jong Ho Moon; Joon Seong Lee; Chan Sup Shim
Journal:  Surgery       Date:  2009-06-28       Impact factor: 3.982

Review 5.  Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis: a tale of 3 countries.

Authors:  Wilson M S Tsui; Polly W Y Lam; Wai-Ki Lee; Yiu-Kay Chan
Journal:  Adv Anat Pathol       Date:  2011-07       Impact factor: 3.875

6.  Outcomes of liver resection for intrahepatic stones: a comparative study of unilateral versus bilateral disease.

Authors:  Shao-Qiang Li; Li-Jian Liang; Bao-Gang Peng; Yun-Peng Hua; Ming-De Lv; Sun-Jun Fu; Dong Chen
Journal:  Ann Surg       Date:  2012-05       Impact factor: 12.969

7.  Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

Authors:  Steven C Katz; Kristin Ryan; Naseem Ahmed; George Plitas; Umer I Chaudhry; T Peter Kingham; Seema Naheed; Cang Nguyen; Ponnandai Somasundar; N Joseph Espat; Richard P Junghans; Ronald P Dematteo
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

8.  Endoscopic treatment of biliary disorders in patients with Roux-en-Y hepaticojejunostomy via a permanent access loop.

Authors:  E Parlak; S Disibeyaz; E Oztas; B Cicek; M Ulas; Y Ozogul; E Ozdemir; T Olcer; N Sasmaz; B Sahin
Journal:  Endoscopy       Date:  2010-11-24       Impact factor: 10.093

9.  Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.

Authors:  Hyo Jung Kim; Jae Seon Kim; Sang Jun Suh; Beom Jae Lee; Jong-Jae Park; Hong Sik Lee; Chang Duck Kim; Young-Tae Bak
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

10.  Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.

Authors:  Michael C Ober; Torsten Hoppe-Tichy; Jörg Köninger; Oliver Schunter; Hans-Günther Sonntag; Markus A Weigand; Jens Encke; Carsten Gutt; Stefanie Swoboda
Journal:  J Antimicrob Chemother       Date:  2009-09-04       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.